# Study to Confirm the AuthenTicity of Point of Care Urine samplEs Using Oral fluoreScein Sodium in adulTs With substancE Use Disorder (ATTESTED)

> **NCT07356349** · PHASE3 · NOT_YET_RECRUITING · sponsor: **UpTru Inc.** · enrollment: 114 (estimated)

## Conditions studied

- Substance Use Disorder (SUD)

## Interventions

- **DRUG:** Fluorescein
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT07356349
- **Lead sponsor:** UpTru Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2026-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07356349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07356349, "Study to Confirm the AuthenTicity of Point of Care Urine samplEs Using Oral fluoreScein Sodium in adulTs With substancE Use Disorder (ATTESTED)". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT07356349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*